Clinical Trial

DETERMINE: Detemir vs NPH

Study acronym: DETERMINE
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2023 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-11-05; most recent amendment 2025-11-13.
Status change: Active, Not Recruiting → Completed 2025-11-13
Status change: Recruiting → Active, Not Recruiting 2025-07-10
Status change: Not Yet Recruiting → Recruiting 2022-04-25
Trial Details
NCT Number NCT05124457
Lead Sponsor University of California, Los Angeles
Conditions Gestational Diabetes, Diabetes Mellitus, Type 2
Enrollment 336 participants
Start Date 2022-02-01
Primary Completion 2025-06 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2023-09-26